Evidence map›Paper›PMID 33077648›Full record

ArticleAntimicrobial agents and chemotherapy2020

Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an

Razieh Kebriaei, Katherine L Lev, Kyle C Stamper, Susan M Lehman, Sandra Morales, Michael J Rybak

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Impact ofAntimicrobial agents and chemotherapy · 2026
    Article
  4. CRISPR-driven strategies to disrupt methicillin-resistantFrontiers in cellular and infection microbiology · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Bacteriophage therapy for drug-resistantFrontiers in cellular and infection microbiology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Methicillin ResistantInfection and drug resistance · 2023
    Review
  18. Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Razieh KebriaeiAnti-Infective Research Laboratory, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
Katherine L LevAnti-Infective Research Laboratory, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
Kyle C StamperAnti-Infective Research Laboratory, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
Susan M LehmanAmpliPhi Biosciences Corporation, San Diego, California, USA.
Sandra MoralesAmpliPhi Biosciences Corporation, San Diego, California, USA.
Michael J RybakAnti-Infective Research Laboratory, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA m.rybak@wayne.edu.ORCID 0000-0003-2220-0081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to test the efficacy of bacteriophage-antibiotic combinations (BACs)

Indexed as

BacteriophagesMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsbacteriophagecombinationinfective endocarditis

Identifiers

PMID33077648
PMCPMC7927802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.